Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries
Highlight
This comparative study of Japanese heart failure (HF) registries demonstrated significant temporal improvements in clinical practice and patient outcomes from 2013 to 2019-21. Key highlights include increased use of guideline-recommended pharmacotherapies such as renin-angiotensin system inhibitors and beta-blockers, expanded implementation of cardiac rehabilitation and nutritional guidance, and notable reductions in 1-year mortality and HF readmission rates.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.